Viridian Therapeutics, Inc. (NasdaqCM: VRDN)
Health Care · Biotechnology · US
$18.42
-1.29% today · -11.1% 1Y
Viridian Therapeutics, Inc. (NasdaqCM: VRDN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.11B and employs 252 people.
Over the last twelve months the share price has lost 11.1%, trading between 13.18 and 34.29.
Tweenvest scores Viridian Therapeutics, Inc. across four factors: quality 37/100, value 56/100, growth 71/100. Its strongest factor is growth.
VRDN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.11B
- Revenue (TTM)
- $71.13M
- P/E
- —
- EPS
- -3.46
- Dividend yield
- —
- Beta (5Y)
- 1.10
- 52-week high
- $34.29
- 52-week low
- $13.18
- Avg volume (3M)
- —
- Shares outstanding
- 113.29M
- Employees
- 252
- Next earnings
- —
About Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. is a biotechnology firm committed to creating therapies for patients afflicted by serious illnesses. Its primary development efforts include VRDN-001, a humanized monoclonal anti-IGF-1R antibody currently advancing through Phase 1/2 clinical trials for thyroid eye disease (TED). The company's portfolio also features VRDN-002, an IGF-1R antibody undergoing Phase 1 clinical evaluation, alongside VRDN-003, a therapeutic antibody also designed to target IGF-1R for TED. Established in 2006, this Waltham, Massachusetts-based firm previously operated as Miragen Therapeutics, Inc., before changing its name to Viridian Therapeutics, Inc. in January 2021.
- ISIN
- US92790C1045
- Founded
- 2010
- Listed since
- Jun 18, 2014
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioCryst Pharmaceuticals, Inc.NasdaqGS: BCRX | $2.18B | $8.36 | -2.28% |
| Vera Therapeutics, Inc.NasdaqGM: VERA | $2.15B | $28.17 | -5.72% |
| SK bioscience Co.,Ltd.KOSE: A302440 | $2.13B | ₩36,750.00 | +0.68% |
| Anhui Anke Biotechnology (Group) Co., Ltd.SZSE: 300009 | $2.12B | CN¥8.53 | +1.79% |
| Duality Biotherapeutics, Inc.SEHK: 9606 | $2.11B | HK$182.70 | -6.64% |
| Novavax, Inc.NasdaqGS: NVAX | $2.10B | $12.55 | -1.61% |
| Mineralys Therapeutics, Inc.NasdaqGS: MLYS | $2.07B | $22.31 | -4.54% |
| AlvotechNasdaqGM: ALVO | $2.06B | $5.52 | -4.58% |
Figures last refreshed Oct 11, 2026.